therefore, beyond post hoc analysis of these trials, we do not have evidence that it is the glucose-lowering by these agents that confers the CVD and renal benefit As such, based on physician judgment and patient preferences, select patients, especially those with little comorbidity and long life expectancy, may benefit from adopting more intensive glycemic targets if they can achieve them safely without hypoglycemia or significant therapeutic burden
Most people build it into their routine easily and the injection itself takes seconds
But for some women, theres an unexpected change along the way increased hair shedding
Order this panel before starting GLP-1 medications to establish baseline values, then every 3-6 months during ongoing treatment
Step 5: Inject air and draw medication
The Role of Financial Barriers